The Hantaan virus project discussed in the article was most likely an Ichor product. http://clinicaltrials.gov/ct2/show/NCT01502345 However, the muscle to the skin aspects - the development of new delivery mechanisms are clearly within the scope of Inovio's involvement with biodefense vaccines in which their stated goal was to develop a device that will be able to simultaneously administer multiple synthetic vaccines.